Inventor · disambiguated record
Graeme Semple
Also filed as: SEMPLE GRAEME
28 granted patents·18 pending applications·351 citations·filing 1993–2022
96Inventor score
Top patents by PatentIndex Score
46 records- 0193US7132426B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Nov 7, 2006·56 cites·57 claims
- 0291US7470699B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Dec 30, 2008·41 cites·57 claims
- 0389US10392390B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2016·Granted Aug 27, 2019·6 cites·16 claims
- 0488US7625906B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Dec 1, 2009·11 cites·50 claims
- 0586US8410119B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoJONES ROBERT M·Filed 2009·Granted Apr 2, 2013·8 cites·54 claims
- 0686US6214798B1GnRH antagonists being modified in positions 5 and 6FERRING BV·Filed 1998·Granted Apr 10, 2001·62 cites·20 claims
- 0786US5925730AGnRH antagonistsFERRING BV·Filed 1997·Granted Jul 20, 1999·60 cites·21 claims
- 0882US11780827B2Substituted 3-phenoxyazetidin-1-yl-pyrazinesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 10, 2023·1 cites·11 claims
- 0982US5821230AGnRH antagonist decapeptidesFERRING BV·Filed 1997·Granted Oct 13, 1998·57 cites·20 claims
- 1081US10836764B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2017·Granted Nov 17, 2020·2 cites·39 claims
- 1181US10624900B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2019·Granted Apr 21, 2020·1 cites·25 claims
- 1281US7241792B2Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2005·Granted Jul 10, 2007·4 cites·62 claims
- 1380US10272094B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2016·Granted Apr 30, 2019·1 cites·49 claims
- 1476US2023055376A15-ht2c receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2022·Application pending·0 cites
- 1575US9676758B21-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2016·Granted Jun 13, 2017·3 cites·41 claims
- 1673US8293751B21,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemiaJONES ROBERT M·Filed 2004·Granted Oct 23, 2012·8 cites·85 claims
- 1773US7612106B2Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2006·Granted Nov 3, 2009·1 cites·54 claims
- 1873US7176195B2Fused azepine derivatives and their use as antidiuretic agentsFERRING BV·Filed 2001·Granted Feb 13, 2007·8 cites·18 claims
- 1966US11395824B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2020·Granted Jul 26, 2022·0 cites·6 claims
- 2063US2009258892A1Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2009·Application pending·0 cites
- 2162US11608339B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2020·Granted Mar 21, 2023·0 cites·20 claims
- 2260US12115157B23-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2022·Granted Oct 15, 2024·0 cites·15 claims
- 2360US2007072844A1Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Application pending·0 cites
- 2459US2007082874A1Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARMACEUTICLAS INC·Filed 2006·Application pending·0 cites
- 2557US2024376090A1Isoxazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disordered related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2654US7803837B24-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·0 cites·34 claims
- 2754US2007032537A15-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseasesARENA PHARM INC·Filed 2004·Application pending·0 cites
- 2853US2007093545A14-Oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2004·Application pending·0 cites
- 2951US8933083B21,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemiaJONES ROBERT M·Filed 2012·Granted Jan 13, 2015·0 cites·37 claims
- 3051US8637555B2Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2004·Granted Jan 28, 2014·0 cites·2 claims
- 3150US8546429B21,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoJONES ROBERT M·Filed 2010·Granted Oct 1, 2013·0 cites·29 claims
- 3250US2010331312A1Modulators of the histamine h3 receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2009·Application pending·0 cites
- 3348US5962451ABenzodiazepin derivatives useful as CCK-receptor antagonistsFERRING BV·Filed 1997·Granted Oct 5, 1999·8 cites·20 claims
- 3446US9365511B2Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disordersARENA PHARM INC·Filed 2014·Granted Jun 14, 2016·0 cites·28 claims
- 3546US5688943ABenzodiazepine derivatives useful as CCK-receptor antagonistsYAMANOUCHI PHARMA CO LTD·Filed 1993·Granted Nov 18, 1997·6 cites·16 claims
- 3646US2007072924A1Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2006·Application pending·0 cites
- 3746US2011082134A11,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemiaARENA PHARM INC·Filed 2010·Application pending·0 cites
- 3846US2010240653A1Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related theretoSANTORA VINCENT J·Filed 2007·Application pending·0 cites
- 3945US2007066590A1Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolismJONES ROBERT M·Filed 2004·Application pending·0 cites
- 4044US2006122240A1Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereofARENA PHARM INC·Filed 2003·Application pending·0 cites
- 4142US5728829AProcess of preparing benzodiazepine compounds useful as antagonists of CCK or of gastrineFERRING RES LTD·Filed 1994·Granted Mar 17, 1998·7 cites·6 claims
- 4242US2009036434A1Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2005·Application pending·0 cites
- 4341US2004186104A1Novel pyridinone and related heterocyclic derivativesFiled 2002·Application pending·0 cites
- 4441US2005197350A1Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereofARENA PHARM INC·Filed 2004·Application pending·0 cites
- 4541US2006167270A15-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemiaARENA PHARM INC·Filed 2003·Application pending·0 cites
- 4636US2009036448A1Pyrimidine derivatives and methods of treatment related to the use thereofTAISHO PHARMECUTICAL CO LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Graeme Semple files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →